Published in
Taylor and Francis Group, Statistics in Biopharmaceutical Research, p. 1-15, 2021
DOI: 10.1080/19466315.2021.1874507
Links
Tools
Robust Design and Analysis of Clinical Trials With Nonproportional Hazards: A Straw Man Guidance From a Cross-Pharma Working Group
Journal article published in 2021 by
Satrajit Roychoudhury 
,
Keaven M. Anderson,
Jiabu Ye,
Pralay Mukhopadhyay
,
Keaven M. Anderson,
Jiabu Ye,
Pralay Mukhopadhyay
Distributing this paper is prohibited by the publisher
Full text: Unavailable
Preprint: archiving forbidden
Published version:
archiving forbidden
Data provided by 